ALX Oncology

Updated: August 05, 2025

Founder Jaume Pons

Country: USA | Funding: $329.2M (+)

Website: http://alxoncology.com/

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Competitors